The epidemiology, toxidromic classification, general management, and prevention of mushroom poisoning in the United States.
Since the 1950s, reports of severe and fatal mushroom poisonings have increased worldwide. Clinicians must consider mushroom poisoning in the evaluation of all patients who may be intoxicated by natural substances. Because information on natural exposures is often incorrect or insufficient, a new syndromic classification of mushroom poisoning is proposed to guide clinicians in making earlier diagnoses, especially in cases where only advanced critical care, including kidney or liver transplantation, may be life saving.
Diaz
James H
JH
School of Public Health, Louisiana State University Health Sciences Center, New Orleans, USA.
D000079:Acetaldehyde / Q000009:adverse effects / Q000031:analogs & derivatives; D058186:Acute Kidney Injury / Q000209:etiology; D006801:Humans; D009116:Muscarine / Q000506:poisoning; D009145:Mushroom Poisoning / Q000145:classification / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D009183:Mycotoxins; D010277:Parasympathomimetics / Q000506:poisoning; D012206:Rhabdomyolysis / Q000209:etiology; D013577:Syndrome; D013997:Time Factors; D014481:United States / Q000453:epidemiology
D009183:Mycotoxins; D010277:Parasympathomimetics; D009116:Muscarine; D000079:Acetaldehyde; C005666:gyromitrin